Preliminary Trial of SNA014 for Pancreatic Cancer
Recruiting
Early Phase 1
Interventional Study
Pancreatic Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 12 (estimated)
- Sponsor
- SmartNuclide Biopharma · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for pancreatic cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged between 18 and 75 years (inclusive);
2. Possessing legal capacity, voluntarily participating in this clinical trial, and having signed the informed consent form (ICF);
3. Patients with a confirmed diagnosis of pancreatic cancer whose tumours are suitable for Claudin-18.2…
Contacts